Fundraising Fox

Christopher Gagliardi

InvestorFounder

Investor at Sanofi Ventures · Board director at AdvanCell

Boston, Massachusetts

Writes $5M – $10M checks · typically $7.5M

FoundedAdvanCell

About

Christopher Gagliardi is Ph.D.-trained with a consulting background, serves as Board Observer at Lifordi Immunotherapeutics, and is publicly associated with over 40 life sciences and healthcare investments.

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Board director at AdvanCell

Intro paths

→

In turn, Christopher can intro founders to AdvanCell's investors below.

AdvanCell's investors · 8

AbingworthLondon · $15M – $30M checks · since 2026Ally Bridge GroupNew York · since 2026Bain Capital Life SciencesBoston · since 2026Catalio Capital Management, LPNew York · since 2026Proto AxiomSydney · since 2026Sanofi VenturesCambridge · $5M checks · since 2026SV Health InvestorsBoston · $1M – $20M checks · since 2026Tenmilesince 2026

Co-founders at AdvanCell

AAAndrew Adamovich
Andrew AdamovichDirector
PL
Philina LeeExecutive Officer, Director
APAaron Pickett
Aaron PickettExecutive Officer

Experience

  1. SanofiPrincipal, Sanofi Venturescurrent2023 — presentGreater Boston
  2. SanofiDirector of Investments, Sanofi Ventures2017 — 2023Greater Boston
  3. QuantX BiosciencesBoard Membercurrent2025 — presentShanghai, China
  4. Diagonal TherapeuticsBoard Observercurrent2026 — presentBoston, Massachusetts, United States
  5. AdvanCellBoard Membercurrent2024 — presentBrisbane, Queensland, Australia
  6. Atalanta TherapeuticsBoard Observercurrent2024 — presentBoston, Massachusetts, United States
  7. Sudo BiosciencesBoard Membercurrent2023 — presentCarmel, Indiana, United States
  8. Minervax ApSBoard Membercurrent2020 — presentCopenhagen, Capital Region of Denmark, Denmark
  9. Avilar TherapeuticsBoard Observercurrent2023 — presentGreater Boston
  10. NextPoint Therapeutics, Inc.Board Observercurrent2022 — presentGreater Boston
  11. Matchpoint TherapeuticsBoard Observercurrent2022 — presentGreater Boston
  12. i2o TherapeuticsBoard Membercurrent2020 — presentGreater Boston
  13. L.E.K. ConsultingConsultant2015 — 2017Greater Boston
  14. Graz University of TechnologyResearch Assistant/Intern, Department of Inorganic Chemistry2006Graz, Austria
  15. Marine Biological LaboratoryMarine Resources Center2005Woods Hole, Massachusetts

Education

  1. Harvard UniversityPostdoctoral Research Fellow
  2. The University of North Carolina at Chapel HillDoctor of Philosophy (Ph.D.), Inorganic Chemistry
  3. Roger Williams UniversityBachelor of Science (B.S.) Chemistry, Bachelor of Science (B.S.) Biology

Skills & more

Spectroscopy7Electrochemistry4UV/Vis5Life Sciences5Strategy2Financial Modeling1Asset Life Cycle Management1Pharmaceutical Industry2Biotechnology1Revenue Forecasting

Languages I have a basic knowledge of German

From Christopher's professional profile.

Investments

Board seats

AdvanCell, Inc.

Per SEC Form D filings.

Colleagues at Sanofi Ventures

Anne
Investor at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Camille Ridel
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Francesc Dosrius Lleonart
Associate Director of Investments at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Jim Trenkle
Investor at Sanofi Ventures

Network5

Camille Ridel
Investor at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Jim Trenkle
Investor at Sanofi Ventures
Laia Crespo
Partner at Sanofi Ventures

Investors connected to Christopher in public investor directories — a warm-intro map.

Frequently asked questions

Where does Christopher Gagliardi work?
Christopher Gagliardi is Investor at Sanofi Ventures and Founder at AdvanCell.
What does Christopher Gagliardi invest in?
Christopher Gagliardi invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
What check size does Christopher Gagliardi write?
Christopher Gagliardi typically writes checks of $5M – $10M.
What companies did Christopher Gagliardi found?
Christopher Gagliardi founded AdvanCell.

Same school

Also attended Harvard University1,457

Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures

+ 1,451 more

Also attended The University of North Carolina at Chapel Hill197

Clint MyersInvestor at RevolutionMahati SridharPartner, Rise of the Rest at RevolutionEric WagnerVP of Research and Data at Redpoint VenturesSoul DayanInvestor at True VenturesAlex LimInvestor at IVP (Institutional Venture Partners)Alex TaubPrincipal at QED Investors

+ 191 more

Also attended Roger Williams University6

Michael ChagnonVice President, Fund Finance at Bain Capital CryptoMatthew RutlerEVP @ MasterClass at Cosmic Venture PartnersChristian TellesManaging Partner at Expanding CapitalKhouloud TebiniLegal Counsel at SPE Capital PartnersOanh SamDirector, Operations & Experience at Averin CapitalDan ShearholdtVice President of Finance at Structural Capital

Shared employers

Also worked at Sanofi91

Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscoveryRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures

+ 85 more

Also worked at Atalanta Therapeutics1

Arno de WildeInvestor at EQT Life Sciences

Also worked at Minervax ApS6

Sten VerlandVenture Partner at Sunstone CapitalPatrik SobockiPractice Lead Deep Tech and Senior Investment Director at IndustrifondenKabeer AzizCo-Founder and Partner at Adjuvant CapitalVeronica Gambillara FonckPartner at Pureos BioventuresIshaan TewarieVice President at EQT Life SciencesTal ZaksPartner at OrbiMed

Also worked at L.E.K. Consulting138

Chris BischoffInvestment Team at General CatalystMattias LjungmanInvestor at Moonfire VenturesJessica SchultzPartner at NorthzoneFrancois PrinslooInvestor at MedicxiMiranda GuerreroExecutive Assistant at Sapphire VenturesStacey HeroInvestor at Third Rock Ventures

+ 132 more